Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: This phase II trial is studying how well temozolomide works in treating patients
with progressive low-grade glioma.